Sei Investments Co. boosted its position in Ingevity Corp (NYSE:NGVT) by 4.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,812 shares of the company’s stock after purchasing an additional 1,980 shares during the period. Sei Investments Co. owned about 0.12% of Ingevity worth $3,947,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Synovus Financial Corp lifted its position in shares of Ingevity by 961.5% during the second quarter. Synovus Financial Corp now owns 1,380 shares of the company’s stock worth $112,000 after acquiring an additional 1,250 shares in the last quarter. Mount Yale Investment Advisors LLC purchased a new stake in shares of Ingevity during the first quarter worth $147,000. Quantbot Technologies LP lifted its position in shares of Ingevity by 1,735.5% during the first quarter. Quantbot Technologies LP now owns 2,588 shares of the company’s stock worth $190,000 after acquiring an additional 2,447 shares in the last quarter. Adviser Investments LLC purchased a new stake in shares of Ingevity during the second quarter worth $211,000. Finally, First Midwest Bank Trust Division lifted its position in shares of Ingevity by 13.0% during the second quarter. First Midwest Bank Trust Division now owns 4,776 shares of the company’s stock worth $386,000 after acquiring an additional 551 shares in the last quarter. Institutional investors and hedge funds own 92.09% of the company’s stock.

Several equities research analysts have issued reports on NGVT shares. KeyCorp increased their target price on Ingevity from $95.00 to $110.00 and gave the stock an “overweight” rating in a research report on Friday, July 27th. Zacks Investment Research upgraded Ingevity from a “hold” rating to a “buy” rating and set a $111.00 target price on the stock in a research report on Monday, July 30th. Jefferies Financial Group increased their target price on Ingevity to $102.00 and gave the stock a “buy” rating in a research report on Tuesday, July 17th. Oppenheimer restated a “buy” rating on shares of Ingevity in a research report on Wednesday, May 9th. Finally, ValuEngine raised shares of Ingevity from a “hold” rating to a “buy” rating in a report on Saturday, June 16th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. Ingevity has a consensus rating of “Buy” and a consensus target price of $100.33.

Ingevity stock opened at $99.89 on Friday. The firm has a market capitalization of $4.18 billion, a PE ratio of 38.72, a PEG ratio of 2.23 and a beta of 1.30. Ingevity Corp has a fifty-two week low of $58.79 and a fifty-two week high of $101.79. The company has a current ratio of 2.58, a quick ratio of 1.48 and a debt-to-equity ratio of 2.09.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Wednesday, July 25th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.13. The firm had revenue of $308.60 million for the quarter, compared to analysts’ expectations of $305.14 million. Ingevity had a net margin of 14.72% and a return on equity of 46.65%. The business’s quarterly revenue was up 18.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.78 earnings per share. sell-side analysts anticipate that Ingevity Corp will post 3.72 earnings per share for the current year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems.

Featured Story: Average Daily Trade Volume – ADTV

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.